Resources

Get the details on the components of an augmented analytics tool that will provide real value to life science organizations.

Read more

An artificial intelligence (AI)-driven analytics platform specifically trained with life sciences data can solve the pain points that companies experience with traditional analytics tools. AI gives analytics platforms scalability and speed, reducing the time to insights to just a few seconds.

Read more

‍Awareness, Realization of Potential and Trust in Conversational AI ‍Society has had a complex relationship with artificial intelligence (AI), anxiously anticipating what this technology can do to simplify work and enhance lives – but at the same time, viewing it with a degree of skepticism and, perhaps, distrust.

Read more

In the highly competitive pharmaceutical industry, data analysis is essential for gaining market share. Information at the healthcare provider (HCP) level, such as prescriptions and competitive brands’ performance, can help reps tailor presentations for the best outcomes. However, the challenge has been in giving field teams access to easily consumable insights on demand.

Read more

The wait is over. Users now have immediate access to the data and AI predictions without having to wait for middle-man analysis, saving organizations time and money they can’t afford to waste.

Read more

From advancements in product innovation to receiving recognition as an industry “trailblazer,” WhizAI celebrates 2022 as a year dedicated to growth, optimizing client and partner relationships, and generating positive feedback from investors, customers, and influential analysts.

Read more

Domain expertise matters. Consider this: Enterprises choose transportation and logistics companies that have created the specific types of services they need. Businesses seek professional services with experience in their industries and look for consultants with good track records in their markets. However, remember that domain expertise benefits extend to analytics platforms, particularly those deployed for life sciences. 

Read more

WhizAI, a gold sponsor of the PMSA 2022 Fall Symposium, presented alongside BMS in a track session on day 1 of the event. The topic centered on accelerating business planning and data-driven decision-making processes using conversational analytics.

Read more

AI-powered life sciences commercial analytics are helping pharmaceutical companies navigate a healthcare landscape that’s more complex than ever before. First, decision makers and stakeholders are continually changing. Over the past five years, 350 healthcare mergers have led to greater consolidation, and many physicians have become employees of provider organizations rather than practicing independently. 

Read more

Artificial intelligence (AI) in clinical development is streamlining processes, enhancing trial quality, decreasing time to market, and saving millions in clinical development costs. 

Read more

WhizAI set out to achieve a towering goal: Create an analytics platform purpose-built for life sciences that aims to put business users at the center of the analytics process backed by advanced technologies, including artificial intelligence (AI), natural language query (NLQ), and generation (NLG), and deep learning. We’ve been fortunate to assemble a team with years of experience in life science analytics and data science that have helped us reach that goal and innovate every day. 

Read more

Narratives are highly effective in adding contextual information around visualizations making it comprehensible by reading or listening; and create an imperative, qualitative backbone for what you’re analyzing. In most instances, this requires the involvement of third-party products to ensure narratives can be linked to visualizations in order to build out one-off dashboards. But this requires additional IT maintenance, resulting in an increase in development costs—and more.

Read more

Executive SummaryGartner believes we will not return to a “new normal” but rather a “no normal”. Ambiguity and uncertainty are here to stay. This requires innovation and investment in data and analytics.Thinking of unleashing innovation in your organizations? Gartner advise you focus on 4 key areas - Data, Analytics, Decisions, and Governance.“Causal Inference” is coming into a new renaissance. Causal inference is a new toolbox that goes beyond correlation for data scientists to solve problems in fundamentally different ways. Gartner highlights “conversational analytics” as an emerging application for natural language technology use cases.Futurist Lisa Bodell challenged the audience to imagine what work would feel like if you could stop doing mundane work and unnecessary time-sucks, and spend your time on valuable things.

Read more

For decades, life science companies have contended with the challenges of an increasing scale and variety of data while seeking ways to use insights platforms to make information available to decision makers. 

Read more

Augmented analytics for life sciences appeared on Gartner’s Hype Cycle for Life Sciences Commercial Operations for the first time in 2022. By giving employees, regardless of their data science expertise, easy access to insights, augmented analytics shows promise as a valuable addition to life science tech stacks. 

Read more

Gartner® 2022 Hype Cycle™ for Natural Language Technologies (NLT) positions natural language query (NLQ), a form of NLT, in the “Trough of Disillusionment.” All technologies go through this period after a “Peak of Inflated Expectations.” “Interest wanes as experiments and implementations fail to deliver. Investments continue only if the surviving providers improve their products to the satisfaction of early adopters.” – At that point, Gartner places the technology in the “trough” of the Hype Cycle. When “more instances of how the technology can benefit the enterprise start to crystallize and become more widely understood”*, Gartner moves the technology on the cycle to the “Slope of Enlightenment.”

Read more

In his presentation at the WhizAI Partner Summit 2022, Rahul Karkhanis, Commercial Specialist, WhizAI discussed interesting use cases of our solution while the technology-oriented presentation was led by Amitabh Patil, Co-founder & CTO, WhizAI and product management. They highlighted the key differentiators of WhizAI’s domain-specific augmented analytics solution for life sciences.

Read more

The WhizAI Partner Summit 2022 focused on "Reimagining Analytics for Life Sciences and Healthcare". This was a 2-days event focused on business and technology orientation by our leadership. Audiences also had the opportunity to learn about our vision, mission and use cases in life sciences. And, we were privileged to hear from a WhizAI client representing a top 3 global pharma company discussing their implementation journey and business value derived from WhizAI.

Read more

I am excited that WhizAI will be at the PMSA Annual Conference as a gold sponsor next week, hosting a roundtable, leading a presentation session, and being an exhibitor at the show. Most exciting to me as a product manager is we are showcasing our platform capabilities for helping life sciences organizations make better, faster, and smarter decisions. If you're attending PMSA, schedule a meeting with us to see the following WhizAI capabilities in action. 

Read more

Learn why AI-powered analytics solutions for life sciences should provide cognitive insights, understand the human conversation and be zero code and enterprise-ready.

Read more

Life science analytics improve decision-making throughout an organization if you deploy a solution that delivers insights to the right people at the right times.

Read more

Augmented consumer tools are quickly becoming essential for Life Science teams that want to retain a competitive edge. In 2021, Gartner coined the phrase "augmented consumer" as an evolution of the augmented analytics market trend that aims to place insights directly into the hands of a decision-maker, traditionally thought of as a data "consumer."

Read more

Today, life science teams are flooded with data. The recent pandemic accelerated the deluge by pushing everything online: meetings, client conversations, and casual dinners suddenly turned digital. These interactions could be captured and used to influence decisions at all levels if the interpreted data was correct. This highlighted a fundamental challenge: while data-based insights were technically available to everyone willing to wrangle with the current tools, accessing them wasn't always easy or practical. 

Read more

A data explosion is occurring in life sciences. As enterprises integrate more third-party data sources, they expect data-driven employees to become their competitive advantage moving forward.

Read more

Life science company success hinges on data. Business leaders may need data on drugs in clinical trials or regulatory changes this week.

Read more

Events of the past two years have redefined the world in many ways. As work, processes, and systems moved online, the same technology brought specific challenges that previously helped us carry on.

Read more

Life Science organizations are swimming in valuable data that can inform — even drive — critical business decisions. Over the last few years, data-rich companies in the industry have spent millions of dollars modernizing their data collection and management systems. 

Read more

New and emerging augmented consumer platforms are changing our relationship with data.

Read more

With so many enterprise BI analytics solutions on the market, there’s a lot to consider.

Read more

During the past decade, the influence of big data on the life sciences sector has

Read more

When Covid-19 practically eliminated face-to-face interactions for pharmaceutical sales reps, the industry trend toward digital

Read more

Ushering in the New World of Self-Serve Analytics For the past 20 years, every generation

Read more

Is Your Life Sciences Company Blinded By Big Data? Imagine that a group of pharmaceutical

Read more

Innovation for business intelligence is speeding up. Right now, we are in the midst of

Read more

Businesses need all the tools they can get to better understand the customer, current and

Read more

Last weekend, my family and I decided to go for a drive.

Read more

Welcome to the new normal- one where working from home is a norm, “Zooming” is akin to Googling, and buying just uppers is the fashion.

Read more

Let us start by saying that we hope everyone is safe and secure. These are

Read more

What a difference a year can make! As I (Rohit Vashisht) sit back and reflect

Read more

Your thoughts are heard! Your wishes granted! | Sales reps, what if we told you

Read more

Dear WhizAI readers, In this dedicated season of giving thanks, we thought it’d be a good

Read more

The Future Pharma 2019 (September 9-11, 2019) attracted over 250 pharma sales and marketing leaders

Read more

Typical Day of a Pharmaceutical Sales Rep Pharma sales reps wear multiple hats and bring

Read more

Future Pharma is an annual event that attracts commercial leadership from the life sciences industry.

Read more

Conversation Intelligence Platform Helps Pharma Sales Operations As a sales leader, you are always on

Read more

Conversational AI Platform Is Your Next Gen Sales Op Tool Sales Operations has come a

Read more

WhizAI & UiPath Combine Forces to Create the Best Cognitive On-Demand RPA Platform in Pharma

Read more

I have been wrestling with this question for a long time now. In fact, from

Read more

“A number is just a number, and without context, it means precisely nothing.” Below, we’ve

Read more

Over 30 sales and commercial ops leaders gathered in New Jersey on March 15 to

Read more

I am thrilled to share that, WhizAI has been featured in Ovum’s “On the Radar”,

Read more

Join WhizAI to Learn How to be Free of Dashboards and Reports The Sales Operations

Read more

We regularly talk to several enterprise leaders and realize that many are clearly recognizing the

Read more